Utilization and outcomes of eribulin in triple negative metastatic breast cancer: Real-world findings

被引：0
|
作者：
Kish, J. K.
Mougalian, S. S.
Copher, R.
McAllister, L.
Zhixiao, W.
Broscious, M.
机构：
[1] Cardinal Hlth Specialty Solut, Dallas, TX USA
[2] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
[3] Eisai Inc, Woodcliff Lake, NJ USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P5-15-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-15-16
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Utilisation and Outcomes of Eribulin in Triple-Negative Metastatic Breast Cancer (TN MBC): Real-World Findings
    Kish, Jonathan K.
    Mougalian, Sarah S.
    Copher, Ronda
    McAllister, Lindsay
    Wang, Zhixiao
    Janevski, Mile
    Broscious, Mary
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 123 - 123
  • [2] Real-world effectiveness outcomes by race in patients with metastatic triple negative breast cancer
    Skinner, K. E.
    Dufour, R.
    Haiderali, A.
    Huang, M.
    Schwartzberg, L. S.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [3] Real-world effectiveness outcomes in patients diagnosed with metastatic triple-negative breast cancer
    Skinner, Karen E.
    Haiderali, Amin
    Huang, Min
    Schwartzberg, Lee S.
    [J]. FUTURE ONCOLOGY, 2021, 17 (08) : 931 - 942
  • [4] Understanding real-world treatment and outcomes in patients diagnosed with metastatic triple negative breast cancer (mTNBC).
    Skinner, Karen E.
    Walker, Mark S.
    Haiderali, Amin
    Schwartzberg, Lee Steven
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [5] Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer
    de Nonneville, Alexandre
    Sabatier, Renaud
    Goncalves, Anthony
    Extra, Jean-Marc
    Tarpin, Carole
    Launay, Simon
    Tassy, Louis
    Viens, Patrice
    Rousseau, Frederique
    [J]. JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (03) : 281 - 283
  • [6] Outcome in Patients with Metastatic Breast Cancer Treated with Eribulin: A Real-world Cohort
    Rush, H.
    Khan, M.
    Li, S.
    Agorastos, A.
    Kristeleit, H.
    [J]. CLINICAL ONCOLOGY, 2018, 30 (06) : E46 - E46
  • [7] Real-world treatment patterns and outcomes among elderly metastatic triple negative breast cancer patients in the United States
    Satram-Hoang, S.
    Bajaj, P.
    Stein, A.
    Hoang, K. Q.
    Momin, F.
    Cortazar, P.
    Reyes, C.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [8] Outcomes of real-world use of eribulin plus trastuzumab for HER2-positive metastatic breast cancer
    Mougalian, S. S.
    Copher, R.
    McAllister, L.
    Radtchenko, J.
    Wang, E. C.
    Broscious, M.
    Yu, H-T
    Kish, J.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [9] EFFICACY AND SAFETY OF ERIBULIN IN PATIENTS WITH TRIPLE NEGATIVE METASTATIC BREAST CANCER: REAL LIFE EXPERIENCE
    Valentinova, Ludmila Manzyuk
    [J]. BREAST, 2017, 36 : S57 - S58
  • [10] Eribulin in heavily pretreated metastatic breast cancer: A real-world data from India
    Mandal, T. K.
    Bajpai, J.
    Kapoor, A.
    Kumar, A.
    Ghosh, J.
    Gulia, S.
    Rath, S.
    Gupta, S.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1264 - S1264
12345